You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PANCURONIUM BROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pancuronium Bromide patents expire, and what generic alternatives are available?

Pancuronium Bromide is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc. and is included in eleven NDAs.

The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pancuronium Bromide

A generic version of PANCURONIUM BROMIDE was approved as pancuronium bromide by DR REDDYS on July 31st, 1990.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PANCURONIUM BROMIDE?
  • What are the global sales for PANCURONIUM BROMIDE?
  • What is Average Wholesale Price for PANCURONIUM BROMIDE?
Summary for PANCURONIUM BROMIDE
Drug patent expirations by year for PANCURONIUM BROMIDE
Medical Subject Heading (MeSH) Categories for PANCURONIUM BROMIDE

US Patents and Regulatory Information for PANCURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072759-001 Jul 31, 1990 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072321-001 Jan 19, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Elkins Sinn PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072059-001 Mar 23, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.